Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Discovery Grants Program - Individual

Université de Montréal

$26,000.00

Reverse genetics study of mammalian reovirus proteins: fundamental studies and possible applications

EF 2016-17

Résumé
Mammalian reovirus has played an important role in our understanding of important biological mechanisms: virus entry, synthesis of nucleic acids and proteins, virus evolution, and much more. In addition to its interest as a fundamental research tool, possible applications are envisaged. Some viruses, such as reovirus, could become our allies rather than just enemies to fight. The ability of reovirus to infect humans and a large range of animal species suggests the possibility of developing novel applications. For example, it is now well established that reovirus preferentially infects and kills cancer cells; it is thus an attractive candidate for ""virotherapy"" against cancer. In the last 20 years or so, members of the laboratory have been very active in the study of various aspects of reovirus replication. Molecular biology, biochemistry, and classical genetics approaches, have been especially useful to dissect the structure and function of many viral proteins. It is proposed to pursue this work in order to develop a better understanding of viral replication and its effects on infected cells, an aspect judged essential for the future development of therapeutic applications. Since 2007, a novel method known as ""reverse genetics"" allows introduction of various changes to the reovirus genome. It becomes relatively easy to produce various viral mutants, relying not only to random mutations but using genetic engineering and ""site-directed"" mutagenesis. This is a major progress to study aspects of viral replication that could not be studied otherwise. Three different proteins will be studied: these play different poorly known roles in virus entry, ability to infect different cells, replicate in and kill these cells. These studies will contribute to long-term objectives aimed at developing and optimizing reovirus' applications in animal and human biology.
Programme
Discovery Grants Program - Individual
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
155580-2012
Name nom
Lemay, Guy
Department département
Microbiologie et immunologie
Organization id
63
Institution établissement
Université de Montréal
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2016
Competition year année de concours
2012
Award amount
26000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1211
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Medical and health sciences
Area of application fr
Sciences médicales et de la santé
Research subject code
5202
Research subject group en
Microbiology
Research subject group fr
Microbiologie
Research subject en
Virology
Research subject fr
Virologie
Partie
5
Nb partie
5
Application title
Reverse genetics study of mammalian reovirus proteins: fundamental studies and possible applications
Keyword
NSERC
Application summary
Mammalian reovirus has played an important role in our understanding of important biological mechanisms: virus entry, synthesis of nucleic acids and proteins, virus evolution, and much more. In addition to its interest as a fundamental research tool, possible applications are envisaged. Some viruses, such as reovirus, could become our allies rather than just enemies to fight. The ability of reovirus to infect humans and a large range of animal species suggests the possibility of developing novel applications. For example, it is now well established that reovirus preferentially infects and kills cancer cells; it is thus an attractive candidate for ""virotherapy"" against cancer. In the last 20 years or so, members of the laboratory have been very active in the study of various aspects of reovirus replication. Molecular biology, biochemistry, and classical genetics approaches, have been especially useful to dissect the structure and function of many viral proteins. It is proposed to pursue this work in order to develop a better understanding of viral replication and its effects on infected cells, an aspect judged essential for the future development of therapeutic applications. Since 2007, a novel method known as ""reverse genetics"" allows introduction of various changes to the reovirus genome. It becomes relatively easy to produce various viral mutants, relying not only to random mutations but using genetic engineering and ""site-directed"" mutagenesis. This is a major progress to study aspects of viral replication that could not be studied otherwise. Three different proteins will be studied: these play different poorly known roles in virus entry, ability to infect different cells, replicate in and kill these cells. These studies will contribute to long-term objectives aimed at developing and optimizing reovirus' applications in animal and human biology.